Suven Pharmaceuticals renamed as Cohance Lifesciences

Suven Pharmaceuticals announced that the Ministry of Corporate Affairs, Government of India (MCA), has approved change of name of the Company from Suven Pharmaceuticals to Cohance Lifesciences, with effect from 07 May 2025. The change of name has been carried on pursuant to the Scheme of Amalgamation.
"The transition to Cohance Lifesciences marks a pivotal moment in our commitment to better serve our customers and their end market. We are building a global CDMO that aims to enable innovation across a broad range of modalities, chemistries, and technologies, to advance solutions for a healthier world " said Cohance Executive Chairman, Vivek Sharma.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

3 days ago

• Business Standard

Sanghvi Movers arm rebrands to Sangreen SioRenew

Sanghvi Movers announced that the Ministry of Corporate Affairs (MCA) has approved the name change of its wholly owned subsidiary from Sanghvi Movers provides medium- to heavy-duty cranes on a rental basis to various private and public sector undertakings. SMLs crane fleet consists of medium- to large-sized hydraulic truck-mounted telescopic and lattice boom cranes and crawler lattice boom cranes having a lifting capacity ranging from 20 MT to 1000 MT. The companys standalone net profit fell 9% to Rs 43.45 crore on a 1.9% drop in revenue from operations to Rs 162.32 crore in Q4 FY25 over Q4 FY24. Shares of Sanghvi Movers shed 0.30% to Rs 284.65 on the BSE.

Mint

3 days ago

• Mint

Dalmia Bharat share price edges higher as promoter raises stake in cement company

Dalmia Bharat share price rose by over 1% during Wednesday's trading session. Keshav Power Limited, a promoter group entity associated with the cement giant, has notably enhanced its stake in the firm by purchasing 6.73 crore equity shares, which accounts for 35.90% of Dalmia Bharat's current paid-up capital. This acquisition was carried out through a Scheme of Amalgamation, which became effective on June 13, 2025, with an appointed date set for April 1, 2023. As a result of this transaction, Keshav Power's direct ownership in Dalmia Bharat Limited has grown from 0.52% to 36.42%. The acquisition was revealed in accordance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Even with the significant alteration in Keshav Power Limited's individual ownership, the total shareholding of the promoter and promoter group in Dalmia Bharat Limited stays constant at 55.84%, as the transaction represents an internal group restructuring. Keshav Power's purchase of shares in Dalmia Bharat stems from a Scheme of Amalgamation ratified by the Hon'ble National Company Law Tribunal (NCLT), Cuttack Bench. The order, issued on May 30, 2025, approved the merger of four transferor companies with Keshav Power Limited (the receiving company). The companies that were amalgamated include: Ankita Pratisthan Limited (Transferor Company 1); Mayuka Investment Limited (Transferor Company 2); Shree Nirman Limited (Transferor Company 3); and Sarvapriya Healthcare Solutions Private Limited (Transferor Company 4). Dalmia Bharat share price today opened at an intraday low of ₹ 2,060.25 apiece on the BSE, the stock touched an intraday high of ₹ 2,085.10 per share. According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One, Dalmia Bharat share price is trading flat today and has remained under pressure throughout the week. The ongoing weakness may persist, with immediate support near ₹ 2,000. On the upside, the ₹ 2,150– ₹ 2,180 zone remains a key hurdle, and only a breakout above this range could revive positive momentum. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Time of India

10-06-2025

• Time of India

Meesho turns public company ahead of $1 billion IPO

Bengaluru: Ecommerce marketplace Meesho formally transitioned into a public limited company, according to recent filings with the Ministry of Corporate Affairs. The move came as the Bengaluru-based firm advanced its plan to shift legal domicile from the US to India and restructure operations under a single onshore entity. Meesho is preparing for a potential $1 billion IPO. The company, incorporated as Fashnear Technologies, received board approval to rename itself Meesho Limited. It also passed a resolution to issue bonus shares worth Rs 411 crore at a 47:1 ratio, increasing paid-up share capital from Rs 8.7 crore to over Rs 420 crore. The bonus issue is a standard pre-IPO step aimed at aligning the capital structure for public listing requirements. Meesho reportedly appointed Kotak Mahindra Capital, Morgan Stanley, JP Morgan, and Citi as lead bankers for the IPO, which is expected to value the company at around $7-10 billion depending on market conditions. The listing is likely to take place in late 2025, subject to regulatory clearances. Founded in 2015 by Vidit Aatrey and Sanjeev Barnwal, Meesho built its business by targeting price-sensitive consumers in India's Tier II and Tier III cities. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Good News: You May Be Richer Than You Think It operates as a zero-commission marketplace for sellers and has differentiated itself from larger players like Amazon and Flipkart through its low-cost structure and mass-market reach. Meesho also launched its inhouse logistics arm, Valmo, last year to bring down delivery costs and increase control over fulfilment. The move to become a public entity follows a broader trend of startups converting into Indian domiciled public companies to comply with Sebi regulations and simplify investor structures ahead of domestic listings. A draft red herring prospectus (DRHP) filing is expected in the coming quarters.